Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–36
Headlines
65
Sources here
7
Companies here
6
Current section Germany Medical Devices news
Latest

finance.yahoo.com Earnings

Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses

Parnassus Investments, an investment management company, released the "Parnassus Core Equity Fund" second quarter of 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 16.83% in the second quarter of 2026, outperforming the S&P 500's 15.20% gain. Performance was supported by holdings in Information Technology and Communication Services, as well as the …

Stock index futures largely flat after S&P 500 closes at record high

[Wall Street New York stock exchange stock market] alexsl Stock index futures were muted on Friday after the S&P 500 closed at a record high in the previous session. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.12%, S&P 500 futures (SPX [https://seekingalpha.com/symbol/SPX]) +0.02%, and Nasdaq futures (US100:IND) …

BSX mentioned
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.3% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Koninklijke Philips (ENXTAM:PHIA) Following Exor Stake Update Still Looks Close To Fair Value

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Koninklijke Philips (ENXTAM:PHIA) has drawn renewed attention after updating its long-term agreement with Exor. The move allows Exor to raise its shareholding to 22%, while existing governance …

PHI1 main company
Sharemaestro market context Price below Trend Line 52 weeks +2.8% · Next-week setup positive 56.0% PHI1 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

The Advertising Research Foundation Announces 2026 ARF David Ogilvy Awards Finalists

NEW YORK, Aug. 13, 2026 /PRNewswire/ -- The Advertising Research Foundation (ARF) today announced the finalists for the 2026 ARF David Ogilvy Awards, honoring excellence in research-driven advertising and marketing. For more than 30 years, the ARF David Ogilvy Awards have recognized campaigns that …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Let's take a look at what these …

BSX main company
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.3% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Here’s What Hurt Boston Scientific Corporation (BSX) in Q2

TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve …

BSX mentioned
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.3% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation

Edwards Lifesciences Corporation EW shares have gained 14% in the past three months as growth across its structural-heart franchises has strengthened the operating case. Second-quarter results showed double-digit expansion in transcatheter aortic valve replacement and faster growth in transcatheter mitral and tricuspid therapies. The …

EWL main company BSX mentioned
Sharemaestro market context Trend signal active 52 weeks +16.7% EWL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

ABL main company BSX mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

ABL main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABL main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?

DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?

DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating leverage can persist as organic growth improves. The guidance increase is encouraging, but foreign exchange, …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?

DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-market access can keep pace …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

ABL main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AI-Enabled Imaging Modalities Market Report: Evaluating AI Software Integration, FDA Approvals, and Competitive Strategies of GE HealthCare, Canon, Siemens, and Philips

Company Logo Accelerating clinical adoption highlighted by GE HealthCare's latest FDA clearance for AI-guided radiation planning, Canon Medical's AI deep-learning CT launch, and strong 2026 order books across Siemens Healthineers and Philips is transforming diagnostic workflows globally. This study delivers an in-depth competitive analysis, …

SHL mentioned PHI1 mentioned
Sharemaestro market context Price above Trend Line 52 weeks -14.0% SHL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

1 Semiconductor Stock for Long-Term Investors and 2 Facing Challenges

1 Semiconductor Stock for Long-Term Investors and 2 Facing Challenges Semiconductors are the silicon backbone of the digital revolution. The amount of data we ingest is also increasing exponentially, leading to elevated demand for chips with more processing power. This secular trend bodes well …

PHI1 mentioned
Sharemaestro market context Price below Trend Line 52 weeks +2.8% · Next-week setup positive 56.0% PHI1 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott tells Proactive's Stephen Gunnion that the Icaco 3 well has confirmed up to four hydrocarbon-bearing zones in the Icaco extension of the Tapir Block in Colombia, opening almost 10 additional development locations across the Ubaque, …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Should Investors Buy Inogen as Low Valuation Meets Execution Risk?

Inogen, Inc. INGN trades at a steep sales-multiple discount even as second-quarter 2026 margins improved and international demand remained firm. The disconnect creates an interesting setup, but the operating recovery is not yet broad-based. Investors must weigh better cost control, expanding respiratory offerings and …

PHI1 mentioned
Sharemaestro market context Price below Trend Line 52 weeks +2.8% · Next-week setup positive 56.0% PHI1 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future …

ABL main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?

AbbVie (NYSE: ABBV) is aiming high with its $10.6 billion planned purchase of Apogee Therapeutics (NASDAQ: APGE). The deal, pending regulatory approvals, is expected to close in the third quarter. The move is designed to supplement the pharmaceutical giant's already strong immunology portfolio. However, …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Pulsed Field Ablation Global Market Report 2026 Now Available - Profiles Boston Scientific, Medtronic, Biosense Webster, and 15 Other Players

Company Logo Pulsed Field Ablation MarketPulsed Field Ablation Market Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Area, Source of Ablation, Key Geographical Regions, and Sales Forecast of Leading Players - Trends and Forecast …

BSX mentioned
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.3% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Royal Philips And Exor Update Long-Term Relationship Agreement

(RTTNews) - Royal Philips (PHG), a health technology company, and Exor N.V., an investment company, announced that they have agreed to update their long-term relationship agreement. Royal Philips provides image-guided therapy, diagnostic imaging, ultrasound, monitoring, and enterprise informatics and made approximately 18 billion euros …

PHI1 main company
Sharemaestro market context Price below Trend Line 52 weeks +2.8% · Next-week setup positive 56.0% PHI1 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped …

ABL main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts' average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised …

ABL mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Michael F. Mahoney, Chairman, President & CEO of Boston Scientific Corporation (NYSE:BSX), purchased 186,240 shares of common stock at $48.34 per share on August 3, 2026. SEC Form 4 filing. Transaction summary Metric Value Transaction value $10.1 million Shares purchased 208,359 Post-transaction shares (total) …

BSX main company
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.3% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?

Abbott Laboratories' ABT Medical Devices remains its largest segment and continues to benefit from a strong pipeline of new product launches and growing adoption across cardiovascular care and diabetes management. The segment is well positioned to capitalize on the expanding global medical devices market. …

ABL mentioned BSX mentioned
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Kraken Delisting Deadline Nears: Holders of 21 Tokens Risk Near-Zero Payouts

kraken delisting. Photo by BeInCrypto Kraken is entering the final stage of its latest delisting cycle, giving holders of 21 tokens until August 27 at 14:00 UTC to withdraw their assets. Afterwards, the exchange begins automatically liquidating remaining balances into markets it warns may …

BSX mentioned
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.3% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Abbott Laboratories (ABT) Could Be 10% Undervalued On Its $1.35b Buyback Update

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories buyback update Abbott Laboratories (ABT) has completed a share repurchase tranche that saw the company buy back 14,015,097 shares for about …

ABL main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 55.5% ABL stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Insider trades: Microsoft, Meta, Pfizer among notable names

[Meta European head office] Derick Hudson Insider transactions were seen across major firms this week, including Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) and Meta (META [https://seekingalpha.com/symbol/META]). The following trades took place between August 3 and August 7. * Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) saw two executives divest a small …

BSX mentioned
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.3% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Boston Scientific (NYSE: BSX) has initiated multiple product recalls covering cardiac ablation generators and vascular access sheaths due to labeling discrepancies and air …

BSX main company
Sharemaestro market context Price below Trend Line 52 weeks -52.2% · Next-week setup negative 40.3% BSX stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context